Page last updated: 2024-09-04

conivaptan and carbetocin

conivaptan has been researched along with carbetocin in 2 studies

Compound Research Comparison

Studies
(conivaptan)
Trials
(conivaptan)
Recent Studies (post-2010)
(conivaptan)
Studies
(carbetocin)
Trials
(carbetocin)
Recent Studies (post-2010) (carbetocin)
188176422759169

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, JAJ; Bonnet, D; Durroux, T; Frantz, MC; Gandía, J; Hibert, M; Le Merrer, J; Loison, S; Marsol, C; Mouillac, B; Pellissier, LP; Pflimlin, E; Valencia, C; Villa, P1
Chini, B; Durroux, T; Guillon, G; Manning, M; Mouillac, B; Stoev, S1

Reviews

1 review(s) available for conivaptan and carbetocin

ArticleYear
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Progress in brain research, 2008, Volume: 170

    Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Lypressin; Oligopeptides; Oxytocin; Peptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Terlipressin; Uterus; Vasodilator Agents; Vasopressins

2008

Other Studies

1 other study(ies) available for conivaptan and carbetocin

ArticleYear
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
    Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19

    Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Disease Models, Animal; Female; HEK293 Cells; Humans; Interpersonal Relations; Ligands; Male; Mice; Mice, Knockout; Psychotropic Drugs; Pyrazoles; Pyrrolidines; Receptors, Opioid, mu; Receptors, Oxytocin; Structure-Activity Relationship

2018